These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 26374993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH, Selley DE, Lichtman AH, Sim-Selley LJ.
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Opposing roles of dorsomedial hypothalamic CB1 and TRPV1 receptors in anandamide signaling during the panic-like response elicited in mice by Brazilian rainbow Boidae snakes.
    Dos Anjos-Garcia T, Coimbra NC.
    Psychopharmacology (Berl); 2019 Jun; 236(6):1863-1874. PubMed ID: 30694375
    [Abstract] [Full Text] [Related]

  • 9. CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus.
    Dos Anjos-Garcia T, Ullah F, Falconi-Sobrinho LL, Coimbra NC.
    Neuropharmacology; 2017 Feb; 113(Pt A):156-166. PubMed ID: 27062913
    [Abstract] [Full Text] [Related]

  • 10. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T, Sutak M, Jhamandas K.
    Neuroscience; 2007 May 25; 146(3):1275-88. PubMed ID: 17395382
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion.
    Ruginsk SG, Uchoa ET, Elias LL, Antunes-Rodrigues J.
    Clin Exp Pharmacol Physiol; 2013 Oct 25; 40(10):698-705. PubMed ID: 23875874
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant.
    Paquette JJ, Wang HY, Bakshi K, Olmstead MC.
    Behav Pharmacol; 2007 Dec 25; 18(8):767-76. PubMed ID: 17989514
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of fluoxetine and LY 367265 on tolerance to the analgesic effect of morphine in rats.
    Ozdemir E, Bagcivan I, Gursoy S, Altun A, Durmus N.
    Acta Physiol Hung; 2011 Jun 25; 98(2):205-13. PubMed ID: 21616779
    [Abstract] [Full Text] [Related]

  • 20. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats.
    Järbe TU, DiPatrizio NV, Li C, Makriyannis A.
    Behav Pharmacol; 2007 Nov 25; 18(7):673-80. PubMed ID: 17912052
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.